Trials / Terminated
TerminatedNCT02748668
Extracorporeal Membrane Oxygenation (ECMO): Blood Cells
Extracorporeal Membrane Oxygenation: Blood Cells
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 371 (actual)
- Sponsor
- Corewell Health West · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the study is to predict outcomes of patients on extracorporeal membrane oxygenation (ECMO) therapy by correlating cytokines and inflammatory cell patterns to clinical outcomes using data collected in the ECMO Registry at Spectrum Health.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Blood specimen collection |
Timeline
- Start date
- 2015-01-20
- Primary completion
- 2023-08-23
- Completion
- 2023-08-23
- First posted
- 2016-04-22
- Last updated
- 2024-06-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02748668. Inclusion in this directory is not an endorsement.